Background: It is not uncommon for imaging examinations of invasive bone and soft tissue sarcoma patients during initial treatment or postoperative follow-up to detect pulmonary nodules. This has important significance in determining the nature of nodules either for tumor staging and therapeutic regimen selection or for prognosis evaluation. Methods: A review was carried out of invasive bone and soft tissue sarcoma patients diagnosed and treated in the department of orthopedic oncology of Beijing Jishuitan Hospital from June 2002 to June 2012. Data from patients who developed pulmonary metastases, diagnosed by imaging and treated surgically, were analyzed for consistency between imaging and postoperative pathological diagnoses. Results: A total of 45 patients with pulmonary metastasis diagnosed by imaging and treated with resection of pulmonary lesions were included in the study. Thirtyeight cases with pulmonary metastases (84.4%) and seven cases without pulmonary metastases (15.6%) were confirmed by postoperative pathological examination. The most common pathological type in the latter patients was tuberculosis, with a total of four cases (57.1%).
Introduction
As is well known, the lung is the most common site of metastases in invasive bone and soft tissue sarcoma (particularly osteosarcoma), and pulmonary metastasis is one of the major risk factors for death in bone and soft tissue sarcoma patients. [1] [2] [3] According to statistics, the overall five-year survival rate for patients with osteosarcoma is 50-60%; however, after the occurrence of pulmonary metastasis, the five-year survival rate for patients with osteosarcoma drops to 37%. 4 At present, the comprehensive treatment mode of chemotherapy combined with surgical resection of pulmonary metastases is the main therapeutic method for bone and soft tissue sarcoma with pulmonary metastases. The results of previous retrospective studies have shown that if the primary tumor is well controlled, radical resection of pulmonary metastases can improve the survival rate of patients. 5, 6 However, there is no lack of bone and soft tissue sarcoma patients with benign pulmonary lesions in clinics and if they are misdiagnosed with pulmonary metastases, overtreatment will be harmful. Therefore, how to identify invasive bone and soft tissue sarcoma patients with benign or malignant pulmonary lesions is an urgent problem. Pulmonary lesions are difficult to diagnose and in order to avoid overtreatment and to determine the nature of the pulmonary lesions combined with bone and soft tissue sarcomas, thoracic surgery is of great significance. Therefore, we retrospectively analyzed the related data of 45 patients with pulmonary metastases diagnosed by imaging and treated with surgery. The aim of this paper was to explore and summarize the coincidence rate between imaging and pathological diagnoses and their characteristics.
Materials and methods

Patients
A review was carried out of invasive bone and soft tissue sarcoma patients diagnosed and treated in the department of orthopedic oncology of Beijing Jishuitan Hospital from June 2002 to June 2012. Patients who met the following criteria were enrolled in the study: (i) the primary tumor was confirmed by pathology; (ii) the standard treatment mode of pre-operative chemotherapy followed by surgery and postoperative chemotherapy, was adopted for the treatment of osteosarcoma;
7 the treatment method for soft tissue sarcoma was radical surgery; patients with postoperative high risk factors (tumor>5 cm, low histological grade, pulmonary metastases) were treated with adjuvant chemotherapy; 8 patients without risk factors were observed regularly; (iii) patients underwent regular chest computed tomography (CT) examinations at first visit, before surgery, and every three months after surgery for two years; and (iv) indications for recommending patients for pulmonary surgery 9 were that the primary tumor was cured and pulmonary metastases after chemotherapy were stable for more than three months, and patients with emerging pulmonary lesions needed to undertake pathological examination to determine strategies for further treatment.
Methods
A Toshiba Aquilion 64-Slice CT (Toshiba Medical Systems Corporation, Beijing, China) was used to scan the chest. The scanning conditions were as follows: 120KV, 20mAs, dose length product (DLP) 99.4mGy, slice thickness 0.8 mm, pitch 1.5. The pulmonary nodules were automatically extracted from the scan images of the chest using Toshiba post processing software (Lung nodules Analysis, Tosiba Medical Systems Corporation) and confirmed by two experienced radiologists; when the radiologists had different views, they could discuss with clinicians and determine the results together.
Chest CT examination revealed typical signs of pulmonary metastases, such as multiple spherical lesions with variable size in both lungs (≥10 mm), with smooth edges, uniform density, more commonly localized in the lower pulmonary fields. 10 Clinical follow-up observation was carried out for patients who could not be definitely diagnosed in the first examination. If regular re-examination using chest CT showed that the pulmonary nodules were larger and increased, or if they shrank or disappeared, a diagnosis of pulmonary metastases could be considered.
Two pathologists with experience in the diagnosis of bone and soft tissue sarcomas checked the pathological slices simultaneously, and wrote a pathological report after comparing the pathology of primary lesions with the postoperative pathology of pulmonary lesions.
The coincidence rate between imaging and pathological diagnoses was analysed and the incidence of bone and soft tissue sarcomas combined with other pulmonary lesions and the classification of common diseases were investigated.
Statistical analyses were performed according to the different pathological results. The coincidence rate between imaging and pathological diagnoses was evaluated using clinical features of the cases and the correlation of CT imaging features of pulmonary lesions (such as lesion edge, lesion location, whether there were signs of lobulation, internal calcification, and pleural retraction) with the pathological features of pulmonary lesions. SPSS16.0 statistical software was applied for statistical analysis and measurement data were analyzed using χ 2 test. A significant difference was defined as P < 0.05.
Results
General features
A total of 45 patients diagnosed with pulmonary metastases by chest CT were included in the study. After the primary lesion was cured and chemotherapy completed, the pulmonary metastases were stable for more than three months. When the emerging pulmonary lesions needed to be examined by pathology for determining the strategies for further treatment, resection of pulmonary lesions was performed. As shown in Table 1 , among the 45 patients, there were 30 men (66.7%) and 15 women (33.3%), with a median age of 22 years (10-61 years). There were 32 cases of osteosarcoma (71.1%), four cases of chondrosarcoma (8.9%), and nine Positron emission tomography (PET)-CT is very expensive for screening, so only 11 cases (24.4%) among the 45 received PET-CT examinations. In these eleven patients, the maximum diameter of pulmonary nodes was 0.87 cm (0.63-4.9 cm), and the average maximum standardized uptake value (SUVmax) was 1.65 (0-6.5), with three cases (27.3%) showing an SUV value greater than two.
Most patients with pulmonary metastases had no obvious symptoms; symptoms similar to those of the primary pulmonary cancer appear at an advanced stage. For example, with spontaneous pneumothorax pleural effusion and pleuritic chest pain are the first clinical manifestations; however, the vast majority of patients had no related positive signs. None of the patients experienced respiratory symptoms, such as chest pain, suffocation, hemoptysis, cough or fever.
Surgical methods
Among the 45 patients undergoing pulmonary surgery, three patients underwent lobectomy and 42 patients underwent pulmonary wedge resection. Two patients underwent secondary wedge resection of pulmonary metastases. Although the areas and purposes of the surgical resections were slightly different, all patients underwent surgery under the thoracoscope and were discharged after three to four days, with no wound complications.
The coincidence rate between pathological and imaging findings
Among 45 invasive bone and soft tissue sarcoma patients with pulmonary metastasis diagnosed by imaging and treated with resection of pulmonary lesions, 38 patients (84.4%) were confirmed pathologically with pulmonary metastases and seven patients (15.6%) were diagnosed pathologically with non-metastatic lesions. Among seven cases with inconsistencies between pathological and imaging findings, the most common pulmonary lesion was tuberculosis (4 cases, 57.1%). Of the remaining three cases, one patient had cryptococcal infection; pathology showed chronic inflammatory cell infiltration and no cancer in one patient; and old subpleural hemorrhage with fibrous tissue hyperplasia in one patient (Fig 1a-e) .
Correlation analysis of clinical and computed tomography morphological features of patients with pulmonary lesions
There were seven patients with an inconsistence between pathological and imaging findings (15.6%), and their clinical and imaging features are shown in Table 2 . Among seven patients with non-metastatic lesions, the average time interval between surgery of the primary tumor and the occurrence of pulmonary lesions was 15.5 ± 31.2 months (0-85.5 months, the median time interval 2.8 months). All seven patients had single lesions: one lesion was centrally located, and the remaining six lesions were located in the periphery of lung. The average size of the pulmonary lesions was 12.5 ± 4.91 mm (6.3-18.4 mm, the median size 15 mm). CT showed that there were three cases (42.9%) of pulmonary lesions with clear edges and four cases (57.1%) with fuzzy edges. All seven patients had no signs of lobulation, pleural retraction, burrs or voids. Three patients had pulmonary lesions after the end of treatment and were treated immediately with pulmonary surgeries; pathology results showed two cases of tuberculosis and one case of cryptococcosis.
Three patients had pulmonary lesions during initial treatment. Two patients underwent pulmonary surgeries when the primary tumors were cured and the pulmonary metastases after chemotherapy were stable. Pathology results showed tuberculosis and chronic inflammatory cell infiltration, with no visible tumors. One patient with a low malignant tumor was observed routinely for six months after primary lesion resection, and then underwent pulmonary surgery. Postoperative pathological results showed tuberculosis. One patient had a pulmonary lesion during chemotherapy and underwent pulmonary surgery when the primary tumor was cured and the pulmonary metastasis after chemotherapy was stable. This case was pathologically considered as old subpleural hemorrhage with fibrous tissue hyperplasia (Fig 1) .
Among 38 patients (84.4%) with coinciding clinical and pathological findings, the average time interval between surgery of the primary tumor and occurrence of the pulmonary lesion was 21.5 ± 22.8 months (0-99.7 months, median time interval 14.4 months), which was slightly longer than that of patients whose clinical and pathological findings did not match, but did not reach statistical significance (P = 0.595). The average diameter of pulmonary lesions was 14.0 ± 8.1 mm (5-41 mm, the median diameter 11 mm), which was slightly greater than that of patients whose clinical and pathological findings did not match, but also did not reach statistical significance (P = 0.278).
Whether the pulmonary lesions of patients were metastatic or not had no relationship with gender (P = 0.403), diagnosis of primary tumor (P = 0.7), surgical method (P = 0.582), resection approach of pulmonary lesions (P = 0.241), pulmonary lesion location (P = 0.216), mineralization on CT (P = 0.302), lobulation (P = 0.182), burrs (P = 0.870), or pleural retraction (P = 0.564). However, these results suggest that when patients with invasive bone and soft tissue sarcoma had multiple pulmonary lesions, the probability of pulmonary lesions to be pathologically confirmed as pulmonary metastases was greater (P = 0.038).
Discussion
It is not uncommon that patients with invasive bone and soft tissue sarcoma tumors, especially osteosarcoma, have small pulmonary nodules found accidentally by chest CT at the first visit or during follow-up; however, once found, how to identify metastases is always a problem for clinicians. Although imaging experts usually take a lesion diameter of more than 1 cm as a threshold value for diagnosis of malignant lesions,
Finishing neoadjuvant chemotherapy
Finishing adjuvant chemotherapy Figure 1 (a-e) A 12-year old female patient, diagnosed with osteosarcoma in the right distal femur. The small pulmonary nodule that occurred during initial treatment gradually enlarged during the process of treatment; the pulmonary lesion was stable after continuing chemotherapy, and then wedge resection of the pulmonary lesion was performed under the thoracoscope. Postoperative pathology showed a non-metastatic lesion.
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Thoracic Cancer 6 (2015) 180-185studies have indicated that a pulmonary lesion of less than 1 cm in diameter also has a high risk of malignancy (48∼58%), and patients with a history of malignant tumor have a higher risk (62-81%). 11, 12 Munden et al. retrospectively studied the illness development situations of 102 tumor patients with small pulmonary nodules accidentally found during the period of follow-up (diameter less than 4 mm), and the results showed that 28% of pulmonary nodules were progressively enlarged, indicating that they were metastatic lesions. 13 For patients with a history of extrapulmonary malignancy, the possibility of combined pulmonary nodules to be considered as metastases in the first instance is greater. However, in terms of the nature of pulmonary nodules, there may be several possibilities, such as primary pulmonary cancer, metastatic tumors, and benign lesions. 10 Determining the nature of pulmonary nodules has important significance for tumor staging, treatment selection, and prognostic evaluation.
Chest CT is considered the most effective means to discover pulmonary metastases. Pulmonary metastases from osteosarcoma and soft tissue sarcoma are usually present as multiple forms; however, the single form is also not uncommon. The morphologies of pulmonary nodules on CT have suggested that significance lies in determining whether pulmonary nodules are primary or metastatic, or even judging the source of metastases.
14,15 However, imaging is less reliable in deducing the nature of this type of pulmonary nodule with a history of extrapulmonary malignancy and it cannot be used as the sole basis for treatment decisions. The study of Peuchot and Libshitz on the relationship between X-ray and surgical findings of pulmonary metastases showed that in 237 pulmonary nodules, the coincidence rate between nodular pulmonary metastases identified by pre-operative CT scan and their surgical findings was only 73%.
11 Pulmonary metastases accounted for 84.4% (38/45) in this group, slightly higher than that reported in the literature. No primary pulmonary cancer was discovered, but the occurrence rate of non-metastatic lesions reached 15.6% (7/45), which also highlights the importance of surgery for pathological diagnosis. In this group, diagnostic accuracy was confirmed pathologically in 84.4% of patients with pulmonary metastases diagnosed by chest CT; however, the false positive rate was 15.6%, suggesting that if relying upon chest CT to diagnose pulmonary metastases in bone and soft tissue sarcoma patients, approximately 15.6% of the patients will be included into advanced stage and, subsequently, receive overtreatment. For the bone and soft tissue sarcoma patients with pulmonary metastases diagnosed by imaging, pathological confirmation should be actively recommended.
There is no dispute on the status of thoracic surgical intervention in the treatment of pulmonary metastases from osteosarcoma and soft tissue sarcoma. Surgical indications include: (i) the tumor in the primary site has been cured; (ii) Pulmonary metastasis in sarcoma patients Z. Huang et al.
there is no extrapulmonary metastasis in other parts of the body; (iii) all metastases must be able to be resected completely; and (iv) a patient with a good heart and lung function can tolerate the surgery. Wedge resection or pulmonary lobectomy is the most common surgical treatment for pulmonary metastases. In the course of surgical resection, normal pulmonary tissues should be retained as far as is possible so that the patient can still accept surgical treatment if the recurrence of pulmonary metastases occurs; meanwhile, the quality of life of patients who cannot undergo surgery again may also be improved. Double lobectomy and even total pneumonectomy should be avoided if possible. The two kinds of surgical method were applied in this group of patients not only in order to remove the tumor, but also to preserve more normal pulmonary tissue. Within the group of seven patents with inconsistences between pathological and imaging findings, tuberculosis accounted for the vast majority of misdiagnosed pulmonary metastases. As immunity is low in patients with malignant tumors, the probability of developing tuberculosis is greater (57.1% in this group of patients). More attention should be paid to remind us to perform purified protein derivative (PPD), erythrocyte sedimentation rate (ESR), and Calmette's tests to assist in differential diagnosis in clinical practice when pulmonary lesions are discovered in patients with extrapulmonary malignancy.
Conclusion
There is a certain degree of misdiagnosis when using imaging for the diagnosis of pulmonary metastasis. Attention should be paid to the pathological diagnosis of pulmonary metastasis in order to avoid overtreatment. This single-center study with a small sample size showed that pulmonary metastases account for about 84.4% of pulmonary lesions combined with bone and soft tissue sarcoma, with a misdiagnosis rate of 15.6%. Tuberculosis is most common in misdiagnosed cases. It is difficult to clearly identify pulmonary lesions in patients with invasive bone and soft tissue sarcoma using imaging; therefore, pulmonary surgery should be performed to determine pathology and avoid overtreatment.
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